Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $2.18 million for the year ending 2024.
- NORTHWEST BIOTHERAPEUTICS INC showed an increase of +2.3% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from NORTHWEST BIOTHERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 1996 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $350.0 thousand | Q1 2011: $1.07 million | Q2 2011: $6.70 million | Q3 2011: $1.64 million | Q1 2012: $37.0 thousand | Q2 2012: $430.0 thousand | Q3 2012: $111.0 thousand | Q1 2013: $373.0 thousand | Q2 2013: $1.99 million | Q3 2013: $2.86 million | Q1 2014: $12.23 million | Q2 2014: $8.85 million | Q3 2014: $1.40 million | Q4 2014: $13.39 million | Q1 2015: $3.17 million | Q2 2015: $19.20 million | Q3 2015: $5.39 million | Q1 2016: $11.69 million | Q2 2016: $2.14 million | Q3 2016: $802.0 thousand | Q1 2017: $2.23 million | Q2 2017: $22.0 thousand | Q3 2017: $1.05 million | Q1 2018: $198.0 thousand | Q2 2018: $1.60 million | Q3 2018: $248.0 thousand | Q1 2019: $1.97 million | Q2 2019: $6.68 million | Q3 2019: $1.97 million | Q4 2019: $372.0 thousand | Q1 2020: $764.0 thousand | Q2 2020: $5.96 million | Q3 2020: $9.25 million | Q1 2021: $7.47 million | Q2 2021: $3.76 million | Q3 2021: $3.84 million | Q1 2022: $6.96 million | Q2 2022: $4.83 million | Q3 2022: $9.43 million | Q1 2023: $6.19 million | Q2 2023: $1.42 million | Q3 2023: $6.10 million | Q1 2024: $2.48 million | Q2 2024: $2.88 million | Q3 2024: $2.94 million | Q4 2024: $2.18 million | Q1 2025: $2.78 million | Q2 2025: $4.32 million | Q3 2025: $4.56 million.
- Historical annual values: Fiscal year 2024: $2.18 million | Fiscal year 2023: $2.13 million | Fiscal year 2022: $6.97 million | Fiscal year 2021: $15.17 million | Fiscal year 2020: $9.98 million | Fiscal year 2019: $372.0 thousand | Fiscal year 2018: $22.22 million | Fiscal year 2017: $117.0 thousand | Fiscal year 2016: $6.87 million | Fiscal year 2015: $21.81 million | Fiscal year 2014: $13.39 million | Fiscal year 2013: $18.50 million | Fiscal year 2012: $7.35 million | Fiscal year 2011: $24.0 thousand | Fiscal year 2010: $153.0 thousand | Fiscal year 2009: $65.0 thousand | Fiscal year 1996: $0.00.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: